Skip to content

The nomination committee appointed for the Annual General Meeting 2025

By

QleanAir AB announces that the nomination committee has now been appointed for the Annual General Meeting 2025. Instructions for the nomination committee can be found on the company’s IR website: https://qleanair.com/investors/ Nomination Committee for the Annual General Meeting 2025 Staffan Persson, appointed by Swedia Capital Fredrik Palmstierna, appointed by Fredrik Palmstierna Dan Pitulia, appointed by Calandrella … Continued

Postponement of Curexa Pharmacy project

By

In May 2024, QleanAir announced a cleanroom agreement with Curexa Pharmacy, with an order value of USD 2 500 000, which was planned for completion during 2024. QleanAir has today recived information from Curexa Pharmacy that they postpone the project. At this time, QleanAir do not know what this means in time or possible extent. QleanAir sees … Continued

Invitation to the presentation of the second quarter report 2024

By

QleanAir invites to teleconference and audio cast on August 9th, at 10.00 am CEST. The company’s CEO, Sebastian Lindström, and CFO, Henrik Resmark, present the interim report for the second quarter 2024 in English. The presentation will start at 10 am and can be joined via the web or by telephone. It will be available … Continued

Curexa Pharmacy a leading provider of specialty compounding services in Egg Harbor Township, NJ has signed an agreement with QleanAir Scandinavia Inc.

By

The agreement is for a 503(A) cleanroom suite for their new location in Gilbert, Arizona. QleanAir AB (publ), the premium provider of clean indoor environment solutions, announces an order for a new QleanSpace cleanroom from Curexa Pharmacy. The agreement value is projected at approximately USD $2,500,000. The new cleanroom suite is expected to be completed … Continued